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Abstract
The ability to form a variety of cell- matrix connections is crucial for angiogenesis to 
take place. Without stable anchorage to the extracellular matrix (ECM), endothelial 
cells (ECs) are unable to sense, integrate and disseminate growth factor stimulated 
responses that drive growth of a vascular bed. Neuropilin- 2 (NRP2) is a widely ex-
pressed membrane- bound multifunctional non- tyrosine kinase receptor, which has 
previously been implicated in influencing cell adhesion and migration by interacting 
with α5- integrin and regulating adhesion turnover. α5- integrin, and its ECM ligand 
fibronectin (FN) are both known to be upregulated during the formation of neo- 
vasculature. Despite being descriptively annotated as a candidate biomarker for ag-
gressive cancer phenotypes, the EC- specific roles for NRP2 during developmental 
and pathological angiogenesis remain unexplored. The data reported here support 
a model whereby NRP2 actively promotes EC adhesion and migration by regulat-
ing dynamic cytoskeletal remodeling and by stimulating Rab11- dependent recycling 
of α5- integrin- p- FAK complexes to newly assembling adhesion sites. Furthermore, 
temporal depletion of EC- NRP2 in vivo impairs primary tumor growth by disrupting 
vessel formation. We also demonstrate that EC- NRP2 is required for normal post-
natal retinal vascular development, specifically by regulating cell- matrix adhesion. 
Upon loss of endothelial NRP2, vascular outgrowth from the optic nerve during su-
perficial plexus formation is disrupted, likely due to reduced FAK phosphorylation 
within sprouting tip cells.
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1 |  INTRODUCTION
Angiogenesis, the formation of neo- vasculature from pre- 
existing blood vessels, is essential to moderate the hypoxic 
stress that arises in tumor microenvironments.1 Sustained 
primary tumor growth therefore relies on the protracted 
stimulation of neighboring endothelial cells (ECs) to acti-
vate appropriate growth factor receptors such as vascular 
endothelial growth factor (VEGF) receptor- 2 (VEGFR2) on 
their cell surface. The ensuing proliferation and integrin- 
dependent migration of ECs toward the angiogenic stimulus 
then results in the formation of a dense network of highly 
permeable blood vessels to re- perfuse the hypoxic tumor 
niche.2
EC migration relies on the cell's ability to propagate inte-
grin outside- in signaling to the extracellular space.3- 5 Upon 
ligand binding, integrins mediate the recruitment of core cy-
tosolic scaffolding proteins at the sites of adhesion to the ex-
tracellular matrix (ECM) to form focal adhesions (FAs).6- 9 
Additional recruitment and clustering of protein kinases such 
as focal adhesion kinase (FAK) at FAs following integrin- 
mediated adhesion to the ECM subsequently enables integrin 
receptors to overcome the limits imposed by the absence of en-
zymatic or kinase activity in their cytoplasmic tails, allowing 
for the potentiated activation of numerous signaling cascades.10 
An essential downstream effector for directional cell migration, 
FAK also indirectly mediates the activation and translocation 
of Rac1 to FAs, which promotes the nucleation and polymer-
ization of actin stress fibers. This enables for the extension and 
protrusion of lamellipodia and filopodia at the leading edge to 
drive cell spreading and migration.7,11,12 Dynamic remodeling 
of the actin cytoskeleton is also coupled to the rapid disassem-
bly and re- assembly of nascent FAs, which utilize actin high-
ways to coordinate integrin transport and trafficking.13- 16
Neuropilin- 2 (NRP2) is a single pass transmembrane re-
ceptor whose upregulation is consistent with an accelerated 
cancer progression in a number of cell types (eg, neuroblas-
tomas,17 non- small- cell lung carcinoma [NSCLC],18 human 
prostate carcinoma, melanoma,19 lung cancer,20 myeloid leu-
kemia,21 breast cancer,22 and pancreatic cancer23). As a selec-
tive co- receptor for members of the VEGF family of growth 
factors, the function of NRP2 has also been implicated in in-
fluencing EC adhesion, migration and permeability during 
angiogenesis, under both physiological and pathological con-
ditions.24- 26 NRP2 has since emerged as a promising candi-
date for targeted therapy against tumorigenesis, however the 
mechanisms by which it integrates and disseminates ECM 
and growth factor signals to coordinate EC responses during 
angiogenesis is as yet unclear.
We have previously shown that endothelial NRP2 drives 
a VEGF- independent, Rac1- mediated mechanism of cell 
adhesion and migration over fibronectin (FN) matrices 
and regulates FA turnover by promoting basal α5- integrin 
recycling.24 Here we show that NRP2 regulates VASP- 
mediated control of actin pattern development to support 
the protrusion of dynamic lamellipodia at the leading edge 
of migrating cells. We also elucidate the existence of a 
NRP2- regulated phospho- FAK (p- FAK)- Rab11 traffick-
ing axis, siRNA- mediated depletion of NRP2 in vascular 
ECs dampening the activation and recruitment of p- FAK 
to α5- integrin containing adhesions. We build on our pre-
vious work by demonstrating that the reduction in FA turn-
over rate elicited by NRP2 silencing leads to an accelerated 
growth of tensin- 1 positive fibrillar adhesions, which in 
turn promotes FN fibrillogenesis. Finally, by utilizing a 
mouse model that expresses a tamoxifen- inducible Cre- 
recombinase under the control of a PDGFb promoter, we 
examine the effects of specifically and temporally depleting 
endothelial NRP2 in vivo. To this end we demonstrate that 
loss of endothelial NRP2 inhibits tumorigenesis, and tran-
siently impairs physiological vascularization of developing 
postnatal retinae. This work highlights the advantages of 
employing endothelial- specific targeting therapies against 
pathological angiogenesis, in addition to providing further 
evidence that NRP2 is a promising anti- angiogenic target to 
impair primary tumor growth.
2 |  MATERIALS AND METHODS
2.1 | Animal generation
NRP2 floxed (NRP2flfl) mice were purchased from Jackson 
Laboratories (Bar Harbour, Maine, USA), and were generated 
by gene target insertion of embryonic stem cells, resulting in 
the insertion of loxP sites flanking exon 1 of the NRP2 gene. A 
loxP- tauGFP FRT- flanked neo cassette was inserted 1 kb into 
intron 1 via homologous recombination. Heterozygous ani-
mals were crossed to an flp recombinase transgenic line for re-
moval of the neo cassette. The PCR analysis to confirm floxing 
was carried out using the following oligonucleotide primers:
Forward (WT) primer (Reaction A): 5′- CAGG 
TGACTGGGGATAGGGTA- 3′
Common primer (Reaction A + B): 5′- AGCTT 
TTGCCTCAGGACCCA- 3′
Forward primer (flfl) (Reaction B): 5′- CCTGA 
CTACTCCCAGTCATAG- 3′
Transgenic mice expressing a tamoxifen- inducible PDGFb- 
iCreERT2 allele in vascular ECs were provided by Marcus 
Fruttiger (UCL, London, UK), and were generated by substi-
tuting the exon 1 of the PDGFb gene by the iCreERT2- IRES- 
EGFP- pA sequence.
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Forward primer: 5′- GCCGCCGGGATCACTC 
TC- 3′
Reverse primer: 5′- CCAGCCGCCGTCGCAA 
CT- 3′
NRP2flfl mice were bred with PDGFb.iCreERT2 mice to 
generate NRP2flfl; PDGFb.iCreER animals. PDGFβ- iCreERT2 
expression was maintained exclusively on breeding males, 
thereby ensuring the generation of both Cre- negative and pos-
itive offspring and enabling the use of littermate controls. All 
animals were bred on a pure C57/BL6 background.
2.2 | Cell isolation, immortalization, and 
cell culture
Primary mouse lung microvascular endothelial cells 
(mLMECs) were isolated from adult mice bred on a pure 
C57/BL6 background. Primary ECs were twice positively 
selected for through their expression of endomucin by mag-
netic activated cell sorting (MACS) as previously described 
by Reynolds and Hodivala- Dilke.27 ECs were immortalized 
using polyoma- middle- T- antigen (PyMT) retroviral transfec-
tion as previously described by Robinson et al28 Immortalized 
mLMECs were cultured in IMMLEC media, a 1:1 mix of 
Ham's F- 12:DMEM medium (low glucose) supplemented 
with 10% FBS, 100 units/mL penicillin/streptomycin (P/S), 
2 mM glutamax, 50 μg/mL heparin (Sigma).
Immortalized mLMECs were cultured on 0.1% gelatin 
coated flasks at 37°C in a humidified incubator with 5% 
CO2. For experimental analyses, plates, dishes and flasks 
were coated in 10  µg/mL human plasma fibronectin (FN) 
(Millipore) overnight at 4°C. Vascular endothelial growth 
factor- A (VEGF- A164: mouse equivalent of VEGF- A165) was 
made in- house as previously described by Krilleke et al.29
2.3 | siRNA transfection
ECs were transfected with non- targeting control siRNA or 
a mouse- specific NRP2 siRNA construct (Dharmacon), sus-
pended in nucleofection buffer (200  mM Hepes, 137  mM 
NaCl, 5 mM KCl, 6 mM D- glucose, and 7 mM Na2HPO4 in 
nuclease- free water; filter sterilized) using the Amaxa 4D- 
nucleofector system (Lonza) under nucleofection program 
EO- 100, according to manufacturer's instructions.
2.4 | Immunocytochemistry
siRNA- transfected ECs were seeded onto FN- coated acid- 
washed, oven sterilized glass coverslips in 24- well plates 
at a seeding density of 2.5 × 104 cells/well. ECs were fixed 
at indicated timepoints in 4% paraformaldehyde (4% PFA) 
for 10 minutes, washed in PBS, blocked and permeabilized 
with 10% goat serum, PBS 0.3% triton X- 100 for one hour at 
room temperature. Cells were incubated in primary antibody 
in PBS overnight at 4°C. Primary antibodies were: anti- α5- 
integrin (clone ab150361; Abcam), anti- p- FAKTyr407 (clone 
44- 650G Invitrogen), anti- Rab11 (clone 3612; Abcam), anti- 
tensin- 1 (clone NBP1- 84129; Novus Biologicals), EDA- FN 
(F6140; Sigma). Coverslips were PBS washed, and incu-
bated with an appropriate Alexa fluor secondary antibody 
diluted 1:200 in PBS for two hours at room temperature. 
F- actin staining was performed by incubating cells in phal-
loidin- 364 diluted 1:40 in PBS for 2 hours at room tempera-
ture during secondary antibody incubation. Coverslips were 
PBS washed again, before being mounted onto slides with 
Prolong Gold containing DAPI (Invitrogen). Images were 
captured either using a Zeiss AxioImager M2 microscope 
(AxioCam MRm camera) at 63x magnification or using 
a Zeiss LSM880 Airyscan Confocal microscope at 63X 
magnification. FA number and size, and EDA- FN fibers/
cell were quantified using ImageJ software as previously 
described by Lambert et al30 XZ confocal sections taken 
across the z- plane were processed to form a 2D projection 
representing the full depth of the cell culture.
2.5 | Western blot analysis
siRNA transfected ECs were seeded into FN- coated six- well 
plates at a seeding density of 5 × 105 cells/well and incubated 
for 48 hours at 37°C in a 5% CO2 incubator. ECs were lysed 
in electrophoresis sample buffer (ESB) (Tris- HCL: 65 mM 
pH 7.4, sucrose: 60 mM, 3% SDS), and homogenized using a 
Tissue Lyser (Qiagen) with acid- washed glass beads (Sigma). 
Following protein quantification using the DC BioRad assay, 
30 µg of protein from each sample was loaded onto 8% po-
lyacrylamide gels and subjected to SDS- PAGE. Proteins 
were transferred to a nitrocellulose membrane (Sigma) and 
incubated in 5% milk powder in PBS 0.1% Tween- 20 (0.1% 
PBST) for 1 hour at room temperature followed by an over-
night incubation in primary antibody diluted 1:1000 in 5% bo-
vine serum albumin (BSA) in 0.1% PBST at 4°C. Membranes 
were washed 3x with 0.1% PBST and incubated in an appro-
priate horseradish peroxidase (HRP)- conjugated secondary 
antibody (Dako) diluted 1:2000 in 5% milk powder in 0.1% 
PBST for two hours at room temperature. Membranes were 
washed again 3x with 0.1% PBST before being incubated 
with a 1:1 solution of Pierce ECL Western Blotting Substrate 
(Thermo Scientific). Chemiluminescence was detected 
on a ChemiDoc MP Imaging System darkroom (BioRad). 
Densitometric readings of band intensities for blots were ob-
tained using ImageJ. Primary antibodies (all used at 1:1000 
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dilution and purchased from Cell Signalling Technology, 
unless noted otherwise) were: anti- NRP2 (clone D39A5), 
anti- HSC70 (clone B- 6; Santa Cruz Biotechnology), anti- p- 
VASPSer157 (clone 3111), anti- VASP (clone 3132), anti- p- 
FAKTyr407 (clone 44- 650G; Invitrogen), anti- tensin- 1 (clone 
NBP1- 84129; Novus Biologicals), anti- GAPDH (60004- 1- 
1g; Proteintech), EDA- FN (F6140; Sigma).
2.6 | Signaling assays
siRNA- transfected ECs were seeded into FN- coated 6 cm cul-
tures dishes at a density of 5 × 105 cells/well and incubated for 
48 hours. ECs were then PBS washed and starved for 3 hours in 
serum free medium (OptiMEM; Invitrogen). VEGF was then 
added at a final concentration of 30 ng/mL at indicated time-
points. ECs were then subjected to lysing, protein quantifica-
tion and protein expression analysis by Western blot.
2.7 | Co- immunoprecipitation assays
siRNA- transfected ECs were seeded into FN- coated 10 cm 
dishes at a density of 2 × 106 cells/dish, and incubated for 
48 hours. ECs were then lysed on ice in lysis buffer as previ-
ously described by Valdembri et al16 in the presence of 100X 
Halt protease inhibitor cocktail (Thermo Scientific) and pro-
tein quantified using the DC BioRad assay. 200 µg protein 
from each sample was immunoprecipitated by incubation with 
protein- G Dynabeads (Invitrogen) coupled to a rabbit anti- α5- 
integrin antibody (clone 4705S, Cell Signalling Technology) 
on a rotator overnight at 4°C. Immunoprecipitated complexes 
were then washed 3x with lysis buffer + 100X Halt protease 
inhibitor, and once in PBS, before being added to and boiled 
in NuPAGE sample reducing agent and sample buffer (Life 
Technologies) for Western blot analysis.
2.8 | Deoxycholate (DOC) buffer- extraction
siRNA- treated ECs were allowed to adhere for 16 hours at 
37°C and 5% CO2. ECs were then lysed in DOC lysis buffer 
(20mM Tris, pH 8.5, 1% sodium deoxycholate, 2mM io-
doacetamide, 2mM EDTA) in the presence of 100X Halt 
protease inhibitor cocktail, cleared by centrifugation, and the 
insoluble fraction isolated. Insoluble fractions were separated 
by SDS- PAGE and subjected to western blot analysis.
2.9 | In vivo CMT19T tumor growth assays
Inducible, endothelial specific deletion of NRP2 was achieved 
by crossing mice expressing the PDGFb.iCreER promoter 
of Cre- recombinase to those floxed for NRP2. NRP2flfl; 
PDGFb.iCreER and NRP2flfl littermate control mice received 
intraperitoneal (IP) injections of tamoxifen (75 mg/kg body-
weight, 2 mg/mL stock) thrice weekly (Monday, Wednesday, 
and Friday) for the duration of the experiment from D4 to 
D17 to induce Cre- recombinase activity. CMT19T lung car-
cinoma cells (CR- UK Cell Production) (1 × 106) were im-
planted subcutaneously (SC) into the flank of mice at D0 
and allowed to grow until D18. On D18, mice were killed, 
tumor sizes measured, and tumor samples fixed in 4% PFA 
for blood vessel density analysis. Tumor volumes were cal-
culated according to the formula: length x width2 x 0.52.
2.10 | Immunofluorescence analysis of 
tumor sections
Tumor sections were fixed in 4% PFA for 10 minutes at RT 
before being washed twice in PBS 0.3% triton- X100, twice 
in PBLEC (1x PBS, 1% Tween 20, 0.1 mM CaCl2, 0.1 mM 
MgCl2, 0.1 mM MnCl2) and incubated in Dako protein block 
serum free (Agilent). Sections were then incubated overnight 
at 4°C in primary antibodies against NRP2 (clone Sc- 13117; 
Santa- Cruz Biotechnology) and endomucin (clone Sc- 65495; 
Santa- Cruz Biotechnology). Following primary antibody 
incubation, sections were washed again twice in PBS 0.3% 
triton- X100 and PBLEC before being incubated in the appro-
priate Alexa fluor secondary antibody for two hours at RT. 
Sections were then blocked in Sudan black for 5 minutes be-
fore being mounted with flouromount + DAPI and imaged at 
10X magnification using a Zeiss AxioImager M2 microscope 
(AxioCam MRm camera). Blood vessel density was assessed 
by counting the number of endomucin- positive vessels per 
mm2 from three representative ROIs/ section, averaged over 
three sections/tumor.
2.11 | In vivo retina assays
Inducible, endothelial specific deletion of NRP2 was 
achieved by crossing mice expressing the PDGFb.iCreER 
promoter of Cre- recombinase to those floxed for NRP2. 
Tamoxifen- induced activation of Cre- recombinase and 
thus deletion of NRP2 was employed via 2 regimes: 
NRP2flfl; PDGFb.iCreER and NRP2flfl littermate control 
mice either received subcutaneous (SC) injections of ta-
moxifen (50 µL, 2 mg/mL stock) on postnatal (P) days 2 
and 3, followed by intraperitoneal (IP) injections of the 
same dose on P4 and 5 before retinas being harvested at 
P6, or mice received IP injections of tamoxifen (50  µL, 
2 mg/mL stock) on postnatal (P) days 7 to 10 before retinas 
being harvested at P12. After dissection, retinas were fixed 
in ice- cold methanol for 30 minutes before being prepared 
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for blocking and immunostaining. First, retinas were per-
meabilized in PBS 0.25% triton- X100 for 30  minutes at 
RT, before being washed twice in PBLEC and then blocked 
in Dako protein block serum free for one hour. Retinas 
were then incubated in primary antibodies against: FITC- 
BS- 1 lectin (clone L2895; Sigma), NRP2 (clone Sc- 13117; 
Santa- Cruz Biotechnology), αSMA (clone Ab21027; 
Abcam), ERG 1 / 2 (clone Ab92513; Abcam), p- FAKTyr407 
(clone 44- 650G Invitrogen), Collagen IV (clone Ab19808; 
Abcam). Following primary antibody incubation, retinas 
were incubated in the appropriate Alexa fluor secondary 
antibody for 1 hour at RT, before being washed twice in 
PBS 0.1% triton- X100 and mounted. Images were captured 
using a Zeiss LSM880 Airyscan Confocal microscope. 
Vascular extension analysis was performed using ImageJ, 
vessel density analysis was performed using AngioTool.
2.12 | Statistical analysis
The graphic illustrations and analyses to determine statistical 
significance were generated using GraphPad Prism 6 soft-
ware and Student's t tests, respectively. Bar charts show mean 
values and the standard error of the mean (+SEM). Asterisks 
indicate the statistical significance of P values: P >.05 = NS 
(not significant), * P  <.05, ** P  <.01, ***P  <.001 and 
****P <.0001.
3 |  RESULTS
3.1 | VASP- mediated actin pattern 
development is sensitive to the loss of NRP2
Angiogenesis relies on the ability of ECs to sense, integrate 
and disseminate signals they receive from the ECM and from 
secreted growth factors in order to adhere and migrate toward 
the angiogenic stimulus.31,32 We have previously used mul-
tiple specific NRP2 siRNAs in both immortalized and pri-
mary mouse- lung microvascular ECs (mLMECs) to identify 
endothelial NRP2 as a key regulator of EC adhesion and mi-
gration by promoting FA turnover and Rac1 activation, inde-
pendent of VEGF- stimulation. Label- free quantitative mass 
spectrometry was additionally utilized to elucidate candidate 
NRP2 interactions with several endocytic and recycling- 
associated trafficking proteins.24
Migrating cells rely on the stimulation of numerous ca-
nonical signaling networks that converge on the organized 
remodeling of the cytoskeleton.33 Actin is the major cytoskel-
etal element in ECs, and continuously undergoes stress fiber 
remodeling into [protrusions to maintain the cell in a motile 
state.7,12,34 Given NRP2's regulation of Rac1 activity, we de-
cided to consider its involvement during actin cytoskeletal 
remodeling in mLMECs. Luo et al, recently reported that 
pancreatic neuroendocrine tumor (PNET)- associated human 
umbilical vein ECs (HUVECs) ectopically overexpressing 
NRP2 formed larger actin- rich lamellipodial protrusions at 
the cell periphery compared to control ECs. This was subse-
quently shown to result from an upregulation of cofilin ac-
tivity, propagating increased rates of actin polymerization at 
the leading edges of the cell.35 To investigate whether NRP2 
is dispensable for actin cytoskeletal remodeling during initial 
adhesion to the ECM, we allowed control (siCtrl) and NRP2- 
siRNA (siNRP2)- treated ECs to adhere to FN for 90 minutes 
before fixation and stained for filamentous actin (Figure 1A). 
While Ctrl ECs formed long linear stress fibers ending in 
actin- rich lamellipodial protrusions, NRP2 siRNA- treated 
ECs appeared more circular, with visibly fewer linear stress 
fibers, protrusions and actin microspikes (Figure 1B). A sim-
ilar observation was reported by Fantin et al, following NRP1 
knockdown in hMVECs, delineating a role for NRP1 in the 
regulation of Rac1- mediated actin pattern development.36,37
To further elucidate the mechanisms by which NRP2 
controls the remodeling of the actin cytoskeleton, we re- 
examined our label- free mass spectrometry data, originally 
performed to take an unbiased approach to identifying can-
didate proteins associating with NRP2 in mLMECs.24 This 
re- analysis revealed a large number of proteins known to be 
involved in regulating the actin cytoskeleton. Of note, this 
included those known to stabilize the spectrin actin network 
such as tropomyosin- 1, members of the Arp2/3 complex, 
including cortactin, which regulates branch nucleation and 
polymerization, and proteins involved in coordinating stress 
fiber development, such as VASP, cofilin- 1, fascin, and 
TRIO- binding protein.35,38- 40 Unlike cofilin proteins, VASP 
functions as a potent regulator of both radial fiber formation 
and chiral actin pattern development, its depletion in fibro-
blasts preventing the transition from initial actin- rich periph-
eral rings to long linear stress fibers that support growth of 
dynamic protrusions.41,42 As NRP2 depletion appeared to 
impair the formation of linear stress fibers, we next investi-
gated whether NRP2 regulates VASP activity by monitoring 
total and phosphorylated VASP expression in the presence or 
absence of VEGF stimulation. While total VASP expression 
was unaltered following NRP2 siRNA treatment, NRP2 de-
pletion elicited a reduction in VASP phosphorylation at resi-
due Ser157 at both 5 and 15 minutes post VEGF stimulation 
(Figure 1C,D). Phosphorylation at Ser157 provides a signal 
for membrane or leading- edge localization of VASP,41,43 
enabling its interaction with FA- associated proteins such as 
FAK, which have important roles in potentiating Rac1 acti-
vation and translocation to newly forming focal adhesions at 
the leading edges of cells.11,44 Taken together, these results 
suggest that NRP2’s modulatory role over Rac1 during focal 
adhesion assembly is dependent upon its ability to promote 
VASP- mediated actin remodeling.
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3.2 | NRP2 promotes FAK 
phosphorylation and recruitment to assembling 
focal adhesion sites in ECs
We next considered whether NRP2 depletion would impair 
FAK phosphorylation. NRP2 has been demonstrated to lo-
calize to p- FAK- positive adhesions in breast- tumor epithelial 
cells allowed to adhere on laminin matrices,45 and to regu-
late FAK signaling during branching morphogenesis in the 
developing mammary gland.46 It is however unclear whether 
NRP2 influences FAK- mediated responses in microvascu-
lar ECs during angiogenesis. Following VEGF stimulation, 
FAK undergoes autophosphorylation at its Tyr397 residue, 
exposing binding sites for Src family kinases, which are in-
volved in phosphorylating additional sites on FAK such as 
Tyr407.47,48 Both residues have been implicated in promot-
ing EC migration and adhesion by potentiating the activa-
tion of downstream signaling cascades, such as the β- PAK 
F I G U R E  1  VASP- mediated actin pattern development and FAK phosphorylation are sensitive to the loss of NRP2. A, siRNA- transfected 
ECs were seeded onto FN coated coverslips and allowed to adhere for 90 min at 37°C and 5% CO2 before being fixed. ECs were then stained 
for filamentous actin using phalloidin Alexa Fluor 568. Images were taken using a Zeiss AxioImager M2 microscope at 63X magnification. 
Arrowheads point to actin microspikes at cell periphery. B, Quantification of number of actin microspikes and actin protrusions/cell, cell circularity 
calculated as 4PiArea/Perimeter2, and cell area (microns2) in Ctrl siRNA and NRP2 siRNA- treated ECs. Two separate NRP2- targeting siRNAs 
(#3 and #4) were tested to confirm results. Error bars show ±SEM; n ≥ 15 cells/siRNA- treated group. Asterisks indicate statistical significance 
from an unpaired two- tailed t test. C, siRNA- transfected ECs were seeded onto FN and allowed to adhere for 48 h at 37°C and 5% CO2. ECs were 
subsequently starved in serum- free medium and stimulated with VEGF (30 ng/mL) for the indicated time. EC extracts were immunoblotted using 
antibodies against NRP2, HSC70, phospho- VASP (p- VASP) (Ser157) and VASP. Panel shows representative western blot image. D, Densitometric 
quantification of mean p- VASP (Ser157) band intensities normalized against total VASP expression and obtained using ImageJ. Error bars show 
±SEM; N = 3 independent experiments. Asterisks indicate statistical significance from an unpaired two- tailed t test (compared to siCtrl)
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interacting exchange factor (PIX)- dependent activation of 
Rac1.11 To assess whether NRP2 regulates FAK phospho-
rylation at either Tyr397 or Tyr407 in mLMECs adhered to FN, 
we assessed the expression of total and p- FAK in a similar 
manner as described above for VASP. At 5 minutes VEGF 
stimulation, NRP2 depleted ECs exhibited a less robust pat-
tern of FAK phosphorylation at both Tyr397 and Tyr407 com-
pared to Ctrl ECs (Figures S1A,B and S2A,B).
Tethering of α5- integrin to FN at assembling adhesion 
sites is required for initial FAK recruitment, aggregation and 
phosphorylation during nascent FA formation.48,49 We have 
previously shown that NRP2 interacts with and regulates the 
recycling of α5- integrin in ECs to promote the assembly of 
FAs at the leading edge.24 As NRP2 depletion impaired FAK 
phosphorylation, we sought to determine whether NRP2 also 
regulates the recruitment of FAK to assembling α5- integrin 
adhesions. As NRP1 disseminates VEGF- mediated signaling 
via the phosphorylation of FAK at Tyr407,47 we focused on 
how NRP2 regulates the interactions between α5- integrin 
and this residue specifically by immunofluorescence confo-
cal microscopy. To this end, we examined the colocalization 
between p- FAKTyr407 and α5- integrin in Ctrl or NRP2- siRNA 
treated ECs allowed to adhere to FN for 90 minutes. While 
Ctrl ECs exhibited a strong colocalizationz between α5- 
integrin and p- FAKTyr407 around the cell periphery within 
large characteristic adhesion structures, NRP2 depleted ECs 
displayed smaller α5- integrin adhesions, and those present 
were less enriched in p- FAKTyr407. In addition, in NRP2 
depleted cells we observed an increased accumulation of p- 
FAKTyr407 around the perinuclear region (Figure 2C- E). To 
confirm that these differences did not arise as an artifact of 
cell immortalization, we quantified the mean adhesion size 
in wild- type (WT)- derived primary and immortalized ECs 
adhered to FN for 90  minutes; we observed no significant 
alterations (Figure  2F). To corroborate these findings, we 
biochemically assessed the physical interaction between α5- 
integrin and p- FAKTyr407 in Ctrl and NRP2 siRNA- treated 
ECs by co- immunoprecipitation. Lysate collected from Ctrl 
ECs displayed a more robust interaction between α5- integrin 
and p- FAKTyr407 compared to lysate collected from NRP2 de-
pleted ECs (Figure 2G), confirming that NRP2 is required for 
the proper recruitment and phosphorylation of FAK during 
FA assembly.
3.3 | NRP2 regulates an α5- integrin- p- 
FAKTyr407- Rab11 trafficking axis
Studies have revealed that the retention of p- FAK within 
endocytosing integrin complexes, including subsequent 
Rab11- associated recycling, sustains the active integrin 
conformation, enabling enhanced polarized reassembly 
of nascent FAs at the leading edge of the cell.34 We have 
previously provided evidence that NRP2 forms associations 
with Rab11 to facilitate α5- integrin recycling.24 As NRP2 
depletion impaired the recruitment and phosphorylation of 
FAK to α5- integrin adhesion sites, we sought to determine 
whether NRP2 regulates an α5- integrin- p- FAK- Rab11 re-
cycling axis to promote FA assembly and development. To 
examine this, we first stained for both Rab11 and NRP2 to 
ascertain their colocalization in mLMECs. NRP2 colocal-
ized with Rab11 at both the perinuclear region of the cell, 
and within trafficking vesicles (Figure S2A), confirming our 
previous co- immunoprecipitation studies and suggesting a 
physical interaction.
To visualize the functional consequences of NRP2 silenc-
ing on Rab11- associated trafficking, we co- immunolabeled 
Rab11 with endogenous p- FAKTyr407 or α5- integrin in Ctrl 
or NRP2 siRNA- treated ECs allowed to adhere on FN for 
90 minutes. As before, with NRP2 knockdown we observed 
a significant accumulation of p- FAKTyr407 arresting within 
the perinuclear region of the cell, and a weaker colocaliza-
tion with fewer Rab11+ vesicles undergoing recycling back 
to assembling adhesion sites at the periphery of the cell 
(Figure  3A,C- E). Furthermore, NRP2 depleted ECs exhib-
ited a dramatic un- coupling of α5- integrin with Rab11+ ves-
icles at both the perinuclear region and at the cell periphery 
(Figure  3B,C,F). These data suggest that NRP2 regulates 
Rab11- facilitated transport of both α5- integrin and p- FAK 
in ECs. Upon NRP2 silencing, assembling nascent adhesions 
are smaller, resulting from a reduced rate of α5- integrin re-
cycling and p- FAKTyr407 recruitment, concomitant with the 
accumulation of both α5- integrin and p- FAKTyr407 at the peri-
nuclear region.
3.4 | Long term depletion of NRP2 
accelerates FA maturation and fibrillogenesis
As FAs mature and become influenced by actomyosin- driven 
forces, their composition transitions from small highly tyros-
ine phosphorylated focal contacts, to large macromolecular 
assemblies.50,51 While focal contacts often translocate by 
extending centripetally and contracting peripherally, and are 
rapidly turned over to promote migration, mature FA com-
plexes anchor to the actin cytoskeleton to mediate more stable 
mechanical changes within the cell. Stress- fiber- associated 
FAs can further mature into fibrillar adhesions after ap-
proximately 24  hours, whereby engaged α5β1- integrin is 
translocated along actin cables centripetally toward the cell 
body. These elongated beaded structures become increas-
ingly enriched with the actin- binding protein tensin- 1 as 
they extend from the medial ends of the stationary FA, and 
act to funnel the necessary actomyosin tension required to 
unfold and integrate secreted FN dimers into an extracel-
lular fibrillar network.52,53 Fibrillar adhesion formation is 
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therefore characteristic of a reduced motility and increased 
cell stability.
Since NRP2 promotes initial FA organization and develop-
ment by regulating Rab11- mediated trafficking of α5- integrin 
and FAK, we considered whether its protracted depletion 
would continue to impair FA maturation. Surprisingly, NRP2 
siRNA- treated ECs adhered to FN for 180 minutes and 16 hours 
exhibited significantly larger α5- integrin positive adhesions 
than their Ctrl siRNA- treated counterparts (Figure 4A). While 
Ctrl siRNA- treated ECs fixed at 16  hours exhibited mature, 
α5- integrin adhesions at the cell periphery, NRP2 depleted 
ECs displayed a high density of characteristic, tensin- 1 positive 
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fibrillar adhesions. Confocal XZ sectioning subsequently con-
firmed the colocalization between endogenous α5- integrin and 
tensin- 1 at the cell body in ECs depleted of NRP2, while in 
our Ctrl ECs tensin- 1 exclusively co- localized with α5- integrin 
at peripheral punctae. This accelerated transition from ma-
ture FAs to fibrillar adhesions was found not to result from 
any changes in total tensin- 1 expression at 16 hours, however 
NRP2 depleted ECs were found to express significantly more 
tensin- 1 at 90 minutes (Figure 4B- D).
Since an extended period of NRP2 depletion appeared 
to promote fibrillar adhesion formation, we asked whether 
this would also influence the polymerization and incorpo-
ration of secreted FN into its ECM. We immunolabeled 
siRNA- treated ECs fixed at 16 hours with antibodies against 
α5- integrin and extra domain- A (EDA)- containing cellular 
FN (EDA FN), which has previously been employed to ex-
amine cell secreted FN specifically.15,52 Confocal micros-
copy revealed that NRP2 silencing significantly increased 
EDA- FN secretion from the cell body and from the ends 
of fibrillar adhesions. We subsequently assessed the rel-
ative quantity of incorporated polymerized EDA- FN in 
lysates collected from both Ctrl and NRP2 siRNA treated 
ECs biochemically, and found that NRP2 depleted ECs ex-
hibited significantly increased levels of insoluble EDA- FN 
(Figure  4E- G). We therefore infer that the initial aberra-
tions in α5- integrin trafficking and FA turnover rate elic-
ited by loss of NRP2 force FAs to instead mature at an 
accelerated rate into fibrillar adhesions. This is accompa-
nied by a concomitant surge in FN fibrillogenesis.
It is worth noting, however, that when siRNA- treated 
ECs were allowed to adhere for 48 hours, we did not ob-
serve any differences in EDA- FN secretion or α5- integrin 
morphology (Figure  4E,H- I), suggesting that any aberra-
tion elicited from NRP2 silencing becomes compensated 
for by this timepoint.
3.5 | Loss of endothelial NRP2 inhibits 
tumor angiogenesis in vivo
Upregulations in FAK activity giving rise to aggressive 
tumor phenotypes has been well substantiated.54- 57 FA as-
sembly and subsequent FAK phosphorylation events in 
turn play a crucial role in FA turnover and remodeling of 
the actin cytoskeleton to promote cancer cell metastasis.58 
NRP2 overexpression is also known to promote tumori-
genicity and metastasis in a multitude of cancer subtypes. 
It therefore represents a potential diagnostic or prognos-
tic biomarker and therapeutic target for inhibiting primary 
tumor growth.59 Despite this, little investigation into its 
contribution during tumor vascularization has been made. 
To isolate the role of NRP2 during tumor angiogenesis, we 
crossed NRP2- floxed (NRP2flfl)- mice to tamoxifen (OHT)- 
inducible PDGFb- iCreERT2 mice and examined the effect 
of an acute EC- specific depletion of NRP2 on subcuta-
neous allograft tumor growth using CMT19T lung carci-
noma cells. Cells were allowed to grow for a period of 18 
d alongside thrice weekly injections of tamoxifen to effec-
tively deplete NRP2 expression within the tumor vascula-
ture (Figure 5A), avoiding the complications of interpreting 
NRP2 function using global knockout models. By tracking 
changes in tumor volume from day 10 post implantation, it 
was also possible to examine any temporal limitations to 
depleting NRP2 in this manner.
Tumors grown in NRP2flfl.PDGFb- iCreERT2- positive 
(Cre- positive) animals developed significantly smaller than 
their control littermate NRP2flfl (Cre- negative) counterparts 
despite no gross changes in mean animal weight (Figure 5B,C, 
Figure S3A). To directly assess the effects of EC- depletion 
of NRP2 on tumor angiogenesis, we performed immunoflu-
orescent analysis on all tumors harvested from Cre- negative 
and Cre- positive mice. After confirming endothelial specific 
F I G U R E  2  NRP2 promotes FAK phosphorylation and recruitment to assembling focal adhesion sites in ECs. A, siRNA- transfected ECs 
were seeded onto FN and prepared as described in Figure 1D. EC extracts were immunoblotted using antibodies against NRP2, p- FAK (Tyr407), 
FAK and HSC70. Panel shows representative western blot image. B, Densitometric quantification of mean p- FAK band intensities normalized 
against total FAK expression and obtained using ImageJ. Error bars show ±SEM; N = 3 independent experiments. Asterisks indicate statistical 
significance from an unpaired two- tailed t test. C, siRNA- transfected ECs were seeded onto FN coated coverslips and allowed to adhere for 90 min 
at 37°C and 5% CO2 before being fixed. ECs were then co- immunostained for α5- integrin and p- FAK (Tyr407). Images were taken using a Zeiss 
LSM880 Airyscan Confocal microscope at 63X magnification. Arrowheads show colocalization at peripheral adhesions. XZ plane images for each 
panel are also shown to display subcellular colocalization. D, Quantification of mean α5- integrin positive adhesion size (microns) between Ctrl 
siRNA and NRP2 siRNA- treated ECs. Error bars show ±SEM; N = 3 independent experiments; n ≥ 180 adhesions/siRNA- treated group. Asterisks 
indicate statistical significance from an unpaired two- tailed t test. E, Quantification of % of p- FAK (Tyr407)- positive α5- integrin adhesions per cell 
between Ctrl siRNA and NRP2 siRNA- treated ECs. Error bars show ±SEM; N = 3 independent experiments; n ≥ 30 cells/siRNA- treated group. 
Asterisks indicate statistical significance from an unpaired two- tailed t test. F) Superplot showing quantification of mean adhesion area (microns2) 
per cell between primary and immortalized mLMECs. Error bars show ±SEM; N = 3 independently derived EC clones (points from each biological 
replicate are shown as a different color where the mean value for each replicate is shown as a larger circle of the same color); n ≥ 60 cells/ group. 
NS=not significant from an unpaired two- tailed t test. G, siRNA- transfected ECs were seeded onto FN and allowed to adhere for 48 h at 37°C and 
5% CO2. EC extracts were immunoprecipitated by incubation with protein- G Dynabeads coupled to a α5- integrin antibody. Immunoprecipitated 
complexes were subjected to western blot analysis using antibodies against p- FAK (Tyr407). NRP2 silencing was confirmed by subjecting the total 
cell lysate to western blot analysis and incubating blots in antibodies against NRP2 and HSC70
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depletion of NRP2 within endomucin- positive blood vessels 
in Cre- positive tumor sections (Figure  5D), we found that 
compared to tumors from Cre- negative animals, those defi-
cient in endothelial NRP2 displayed significantly less vas-
culature (Figure  5E,F). This indicates that the suppressed 
tumor growth and reduced tumor angiogenesis we observe in 
Cre- positive mice likely results from a NRP2- specific, EC- 
intrinsic defect.
3.6 | Deficiency of endothelial NRP2 
transiently impairs neonatal retinal vascular 
development
While pathological and physiological angiogenesis are both 
driven by many of the same processes and stimuli, tumor vas-
culature is very much distinct from physiological vasculature. 
In addition to their highly tortuous organization, vessels that 
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form during tumorigenesis are far leakier than those that form 
under physiological homeostasis.60,61 Studying the effects of 
depleting endothelial NRP2 in a physiological model was 
therefore necessary to obtain any mechanistic insight into its 
function during developmental angiogenesis. To this end, we 
utilized the postnatal mouse retina to examine whether any 
defect arose from inducing EC- specific depletion of NRP2 
at postnatal day 6 (P6) or P12, timepoints during which the 
superficial plexus and the deep plexus are forming respec-
tively.62 Following tamoxifen administration regimens, we 
first confirmed successful depletion of NRP2 by co- staining 
with the endothelial marker BS- 1 lectin in retinas harvested 
from Cre- negative and Cre- positive mice (Figure 6A).
The expression of NRP2 is largely considered to be more 
venous than arterial within the endothelium.63,64 We were 
therefore unsurprised to observe enriched NRP2 expression 
within veins of the superficial plexus by co- immunolabeling 
with α- smooth muscle actin (α- SMA), a marker of smooth 
muscle cells that are known to primarily ensheathe arteries.65 
We also detected NRP2 expression in the disseminating mi-
crovasculature of the superficial plexus, particularly at the 
vascular front. Subsequent multi- plexus analysis revealed, 
however, very little NRP2 expression in the deep vascular 
layer at P12, suggesting that NRP2 plays a more prominent role 
during initial vessel sprouting outwards from the optic nerve 
to the retinal periphery rather than during deep plexus devel-
opment (Figure 6A,B). To examine this further, we compared 
the vascular extension from the optic nerve between retinas 
harvested from Cre- negative and Cre- positive mice and found 
that EC- specific depletion of NRP2 significantly reduced ra-
dial expansion of the vasculature at P6 without affecting ves-
sel density. By comparing the vascular extension of WT and 
PDGFb- iCreERT2- positive (Cre- only) retinas harvested at 
P6, and observing no significant differences (Figure S4A,B), 
we also confirmed that this phenotype did not arise due to 
Cre- toxicity.66 Cre- positive retinas were also found to exhibit 
fewer sprouting ECs at the vascular front, consistent with 
NRP2's expression profile in Cre- negative retinas within the 
superficial layer (Figure  6C- H). Co- staining between BS- 1 
lectin and collagen IV also revealed that Cre- positive retinas 
exhibited significantly more vessels undergoing regression 
within the superficial plexus. This, paired with a significant 
reduction in vessel diameter, suggests that the vasculature of 
Cre- positive mice (Figure S4C- E) is less functional than that 
of their Cre- negative counterparts.
While the existence of FA structures in the developing 
postnatal retina is  disputed, it has been demonstrated that 
FA- associated signaling cascades do exist.37,67 In an attempt 
to corroborate our in vitro findings, we sought to examine 
differential FAK phosphorylation in the retina of our NRP2 
deficient mice. Confocal microscopy of retinas harvested 
at P6 revealed that p- FAKTyr407 staining was greatest at the 
vascular front and enriched at the apical ends of sprouting 
tip cells. p- FAKTyr407 was also detected along the length of 
extending filopodia. However, in retinas harvested from Cre- 
positive mice, the relative intensity of p- FAKTyr407 staining in 
sprouting tip cells was significantly diminished (Figure 6I,J). 
Taken together, this suggests that the reduced vascular exten-
sion and increased vascular regression we observe following 
NRP2 depletion, likely results from the inability of NRP2- 
deficient ECs to form stable cell- matrix interactions.
Defects at P6 were found to be transient however, as at 
P12, retinas from both Cre- negative and Cre- positive mice 
exhibited fully vascularized superficial plexus layers, with 
no gross differences in vessel density (Figure S4F- I). As 
we detected far less robust levels of NRP2 expression in the 
deep plexus layer of Cre- negative retinas compared to at the 
superficial plexus, we were also unsurprised to see the de-
velopment of a normal vascular bed at the deep plexus layer 
in Cre- positive mice (Figure S4J- K). These data suggest that 
NRP2 is primarily involved in promoting initial EC sprout-
ing and vascularization of the superficial plexus rather than 
during deep plexus development.
4 |  DISCUSSION
When considered in conjunction with their interactions 
with other receptors known to regulate angiogenesis, such 
as α5β1- and αvβ3- integrins, the evidence purporting both 
NRPs as pro- angiogenic molecules holds true. For exam-
ple, Valdembri et al, have previously reported that NRP1 
F I G U R E  3  NRP2 regulates a α5- integrin- p- FAKTyr407- Rab11 trafficking axis. A, siRNA- transfected ECs were seeded onto FN coated 
coverslips and allowed to adhere for 90 min at 37°C and 5% CO2 before being fixed. ECs were then co- immunostained for p- FAK (Tyr407) and 
Rab11. Images were taken using a Zeiss LSM880 Airyscan Confocal microscope at 63X magnification. Arrowheads show colocalization. XZ plane 
images for each panel are also shown to display subcellular colocalization. B, As described in (A), ECs were co- immunostained for α5- integrin and 
Rab11. C, As described in (A) ECs were co- immunostained for α5- integrin, p- FAK (Tyr407) and Rab11. D, Quantification of the mean number of 
perinuclear p- FAK (Tyr407)- positive Rab11 vesicles per 3x regions of interest (ROIs) between Ctrl siRNA and NRP2 siRNA- treated ECs. Error 
bars show ±SEM; n ≥ 10 cells/siRNA- treated group. Asterisks indicate statistical significance from an unpaired two- tailed t test. E, Quantification 
of the mean number of peripheral p- FAK (Tyr407)- positive Rab11 vesicles per 3x regions of interest (ROIs) between Ctrl siRNA and NRP2 
siRNA- treated ECs. Error bars show ±SEM; n ≥ 10 cells/siRNA- treated group. Asterisks indicate statistical significance from an unpaired two- 
tailed t test. F, Quantification of the mean number of α5- integrin- positive Rab11 vesicles per cell between Ctrl siRNA and NRP2 siRNA- treated 
ECs. Error bars show ±SEM; N = 3 independent experiments; n ≥ 35 cells/siRNA- treated group. Asterisks indicate statistical significance from an 
unpaired two- tailed t test
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promotes α5β1- integrin- mediated adhesion to FN matrices 
by selectively stimulating its rapid endocytosis from fibrillar 
adhesions and subsequent Rab5- dependent recycling to drive 
FA turnover in ECs.16 Similarly, both we and others have 
demonstrated that NRP2 promotes cellular adhesion and mi-
gration via its interactions with the α5- integrin subunit.24,68 
Further evidence for this has recently been provided by Luo 
et al, who demonstrated that NRP2 may regulate migra-
tion by upregulating cofilin activity, a key mediator of actin 
depolymerization at slow growing filament ends.35 Here, 
we provide evidence that NRP2 associates with a number of 
other proteins known to stabilize and promote actin branch 
nucleation and stress fiber growth, notably cortactin, VASP 
and fascin.38- 41 It is likely therefore, that NRP2 drives the 
simultaneous depolymerization of F- actin at slow- growing 
filament ends to supply the demand for new actin mono-
mers at assembling fast growing ends of extending filopo-
dial protrusions. NRP2- mediated VASP phosphorylation in 
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turn potentiates the rapid polymerization and nucleation of 
F- actin at fast growing ends by initiating the translocation 
and activation of Rac1 to newly forming adhesions.
It is known that aberrations in VASP activity result in re-
duced FAK phosphorylation. For example, VASP inhibition 
has been shown to significantly reduce phosphorylation at 
Tyr- 925 in a human chronic myeloid leukemia (CML) cell 
line, and decrease Tyr397 phosphorylation during Xenopus 
somite development.44,69 As VASP is strongly Ser157 phos-
phorylated at FAs,41,43 we were unsurprised to observe a cor-
responding significant reduction in FAK phosphorylation at 
Tyr397 and Tyr407 sites, both implicated in canonical VEGF 
gradient- driven EC adhesion and migration through their ne-
cessity for correct assembly of nascent FAs. VEGF- mediated 
phosphorylation of FAK at its Tyr407 residue during integrin- 
directed adhesion and migration is also known to be NRP1 
dependent.11,47 While NRP2 has been shown to direct FAK- 
mediated adhesion in cancerous epithelial cells via α6β1,45 
and to support branching morphogenesis in the developing 
mammary gland,46 no connection has been explored in micro-
vascular ECs. Endogenous p- FAKTyr407 staining in fixed ECs 
subsequently revealed that significantly less phosphorylated 
FAK appears to be recruited to α5- integrin positive adhesion 
sites following NRP2 knockdown, resulting in smaller less 
developed FAs. Given we have previously provided evidence 
to suggest that NRP2 exerts a mainly VEGF- independent role 
during EC adhesion and migration,24 we propose that NRP2 
instead promotes FAK auto- phosphorylation following integ-
rin engagement and clustering.
As NRP2 silencing disrupted Rab11- directed recycling 
of α5- integrin- p- FAK complexes back to assembling nascent 
adhesions, it is likely that NRP2 potentiates FAK- mediated 
signaling cascades by regulating the pool of available α5β1- 
integrin capable of binding the FN matrix. In support of this, 
studies have purported that α5- integrin is maintained in an 
active, unliganded conformation when endocytosed with ac-
tive FAK, and during Rab11- mediated recycling.34 This then 
enables more efficient integrin engagement with the matrix, 
and subsequent reassembly of polarized FAs to promote 
directional migration. As we observed a significant loss in 
colocalization between p- FAKTyr407 and α5- integrin within 
Rab11+ vesicles, concomitant with an accumulation of p- 
FAKTyr407 at the perinuclear region, we infer that NRP2 is 
involved in maintaining the interactions between active FAK 
and α5- integrin during vesicular transport.
To our surprise, protracted siRNA- mediated depletion of 
NRP2 accelerated the transition from mature FAs to tensin- 1 
positive fibrillar adhesions translocating α5- integrin to the 
cell body. We believe this to be an artifact arising from aber-
rations in FA turnover rate, whereby FAs are forced to ma-
ture prematurely rather than be dynamically endocytosed and 
recycled. To confirm this model, we examined the effects of 
NRP2 silencing on the assembly of fibrillar FN. This remod-
eling of the extracellular matrix is driven by the actomyosin 
tension accrued from the translocation of α5β1 integrin into 
fibrillar adhesions and is essential during angiogenesis for 
vessel formation.52 Contemporaneous to the surge in fibril-
lar adhesion formation we observed in our NRP2 depleted 
ECs fixed at 16  hours, immunostaining and deoxycholate 
(DOC)- buffer extracted insoluble EDA- FN quantification 
revealed a surge in secreted FN radiating outwards from α5- 
integrin containing adhesions. In support of these findings, 
others have established that Rab11- mediated recycling of 
α5- integrin orchestrates the continuous renewal of polarized 
FN fibrils being secreted to form an extracellular fibrillar 
network.15,52 We propose here that the early defects in FA 
turnover rate elicited by NRP2 depletion, although eventually 
compensated for, sustains the transition to a more sedentary 
cell fate in which the premature development of fibrillar ad-
hesions promotes the integration of secreted FN into insolu-
ble fibrils. By doing so, stability and contractility is favored 
over motility. Alongside other studies,70 this work reinforces 
the growing evidence in multiple cell types that NRP2 defi-
ciency can promote cell contractility.
F I G U R E  4  Long term depletion of NRP2 accelerates FA maturation and fibrillogenesis. A, Mean length of α5- integrin adhesions (µm), error 
bars show mean ± SEM; n ≥ 150 adhesions/timepoint/condition); Asterisks indicate statistical significance from an unpaired two- tailed t test. B, 
siRNA- transfected ECs were seeded onto 6 cm dishes pre- coated with 10 µg/mL FN and incubated for either 90, 180 min or 16 h at 37°C. ECs 
were lysed in ESB and subjected to the DC protein assay before being analyzed by western blotting using primary antibodies against Tensin- 1. 
GAPDH was used as a loading control. C, Bands were quantified using ImageJ densitometric analysis. Error bar shows mean ± SEM; N = 3 
independent experiments; asterisks indicate statistical significance from an unpaired two- tailed t test. D, siRNA- transfected ECs were seeded onto 
FN coated coverslips and allowed to adhere for 16 h at 37°C and 5% CO2 before being fixed. ECs were co- immunostained for α5- integrin and 
tensin- 1. Images were taken using a Zeiss LSM880 Airyscan Confocal microscope at 63X magnification. XZ plane images for each panel are also 
shown to display colocalization. E, As described in D), ECs were allowed to adhere for either 16 for 48 h, before being co- immunolabeled with α5- 
integrin and EDA- FN. F, siRNA- treated ECs were allowed to adhere for 16 h at 37°C and 5% CO2. ECs were then lysed, cleared and the insoluble 
fraction isolated. Insoluble fractions were separated by SDS- PAGE and subjected to Western blot analysis. Membranes were incubated in anti- 
EDA- FN primary antibody to assess quantities of insoluble cell secreted FN, anti- NRP2 primary antibody to confirm NRP2 depletion, and anti- 
HSC70 antibody as a loading control. G, % insoluble EDA- FN. Mean densitometric analysis obtained using ImageJ. Error bars show mean ± SEM; 
N ≥ 3 independent experiments; asterisks indicate statistical significance from an unpaired two- tailed test. H/I, Quantification of EDA- FN density 
at either 16 h (H) or 48 h (I) adhesion to FN. Error bars show mean ± SEM; n ≥ 20 ECs/group. Asterisks indicate statistical significance from an 
unpaired two- tailed t test
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F I G U R E  5  Loss of endothelial NRP2 inhibits tumor angiogenesis in vivo. Inducible, endothelial specific deletion of NRP2 was achieved 
by crossing mice expressing the PDGFb.iCreER promoter of Cre- recombinase to those floxed for NRP2. A, Experimental schematic: tamoxifen- 
induced activation of Cre- recombinase and thus deletion of NRP2 was employed via the following regimen in order to study its role during 
tumorigenesis. NRP2flfl; PDGFb.iCreER (Cre- positive) and NRP2flfl (Cre- negative) littermate control mice received intraperitoneal (IP) injections 
of tamoxifen (75 mg/kg bodyweight) thrice weekly (Monday, Wednesday, Friday) for the duration of the experiment from D- 4 to D17 to induce 
Cre- recombinase activity. CMT19T lung carcinoma cells (1 × 106) were implanted subcutaneously (SC) into the flank of mice at D0 and allowed 
to grow until D18. B, Representative images of tumors harvested from Cre- negative and Cre- positive mice at day 18. C, Quantification of tumor 
volumes measured from tumor bearing Cre- negative and Cre- positive mice measured between day 10 and day 18 post CMT19T injection. Error 
bars show mean ± SEM; N = 3 independent experiments; n ≥ 12 tumors per genotype. Asterisks indicate statistical significance from an unpaired 
two- tailed t test. D, IHC staining using Endomucin and NRP2 primary antibodies to confirm endothelial specific NRP2 deletion in blood vessels 
from Cre- positive tumors. E, Representative tumor sections from Cre- negative and Cre- positive tumors showing endomucin- positive blood vessels. 
F, Quantification of number of blood vessel density per mm2. Mean quantification performed on 3x ROIs per tumor section, from 3x sections per 
tumor. Error bars show mean ± SEM; N = 3 independent experiments; n ≥ 12. Asterisks indicate statistical significance from an unpaired two- 
tailed t test
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In an effort to emphasize the relevance of endothe-
lial NRP2 during angiogenesis and its coordination of α5- 
integrin trafficking in vivo, we modeled the effects of its EC 
specific depletion during both pathological and physiologi-
cal vessel growth. While it has been substantiated by many 
that NRP2 promotes a more aggressive cancer phenotype,59 
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our findings clearly demonstrate that the expansion of tumor 
vasculature to support primary tumor growth is inhibited fol-
lowing loss of endothelial NRP2. Likewise, in the develop-
ing retina, vascular outgrowth from the optic nerve at P6 is 
impaired in animals depleted in endothelial NRP2. NRP2 is 
largely considered to be expressed to a greater extent within 
veins as opposed to arteries,63 however, little is known about 
its expression profile or its endothelial- specific contributions 
during the hierarchical vascularization of the postnatal retina. 
Studies have shown that NRP2 does not compensate for the 
loss of NRP1’s cytoplasmic domain during retina develop-
ment and arterial/venous differentiation.64 Indeed, the pub-
lished evidence outlining the roles of the neuropilins during 
angiogenesis support the principle that NRP1 likely plays a 
more dominant role over NRP2. Despite this, we found that 
vascular extension within the superficial plexus was signifi-
cantly impaired following NRP2 depletion at P6, owing to 
a decrease in the number of sprouting tip cells at the vas-
cular front. These defects were found to likely arise from a 
deficiency in polarized FA- associated signaling, specifically 
FAK phosphorylation within sprouting tip cells, which has 
been previously alluded to be responsible for the formation 
of stable cell- matrix interactions.67 These findings align with 
the expression profile of NRP2, which showed a far more ro-
bust expression at the vascular front of the superficial plexus, 
compared to within the deep plexus layer.
Taken together, these data presented provide evidence that 
endothelial NRP2 plays a key role in regulating both patho-
logical and physiological angiogenesis. We propose a model 
whereby NRP2 promotes FA development by regulating 
α5- integrin trafficking and show that NRP2 is essential for 
vessel development by enabling the formation of stable cell- 
matrix connections.
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